ADHD and Criminals: Drug Corporations Want To Create More Lifetime Customers

Susanne Posel, Contributor
Activist Post

A new study published in the New England Journal of Medicine by Dr. William Cooper, pediatrics and preventive medicine professor at Vanderbilt University, claims that Ritalin and Adderall (two pharmaceutical drugs used to treat ADHD) can prevent the mind of hyperactive children from becoming criminals. Cooper contends that these drugs should continue to be administered through adulthood to prevent criminal activity later in life.

Cooper said:

There definitely is a perception that it’s a disease of childhood and you outgrow your need for medicines. We’re beginning to understand that ADHD is a condition for many people that really lasts throughout their life.

So far, 5% of the children in the US have been diagnosed with ADHD, a psychiatric disorder wherein the non-medical opinion of a psychologist is that a child is hyperactive, impulsive, has difficulty paying attention and therefore must be given pharmaceutical drugs so that “focus in school” can be achieved.

The study analyzed court and prison records from 2006 – 2009 to determine the number of those convicted who were on a drug to treat ADHD; as well as the severity of their crimes. Only 10 control subjects were entered into the study.

The findings showed:

• Thirty – seven percent of convicts were pre-diagnosed with ADHD
• It was likely that ADHD medication was used in 32% of male convicts and 41% of female
• ADHD sufferers were likely to commit burglary or theft
• Four thousand of the 23,000 crimes researched were violent

Paul Lichtenstein, researcher into ADHD for the Karolinska Institute, concurs with the findings of the study (although he had no part in the research). Lichtenstein stated: “It’s well known that individuals with ADHD have much higher rates of criminality and drug abuse than people without ADHD.”

The Karolinska Institute is one of the leading pharmacological research institutions that clarify the field of clinical medicine with the push of the use of drugs to treat physiological and psychological issues. Thirty percent of medicinal training and 40% of medical academic research is conducted at the Karolinska Institute in Sweden, and all lectures are translated into English and taught in universities in the US.

Dr. Andrew Adesman, chief of developmental and behavioral pediatrics at the Steven and Alexandra Cohen Children’s Medical Center, confirms through past research that adults who were diagnosed with ADHD as children are more likely to:

• Get into driving accidents
• Consistently lose jobs
• Divorce spouses
• Be arrested or commit some criminal activity

Adesman admits that not all children marked as ADHD go on to become criminals or divorcees, and that the majority of them simply grow out of the behavior. Yet, Adesman still maintains that despite the fact that ADHD is a phase of childhood that rarely carries into adulthood that “collectively, people with ADHD are at risk for a range of poor outcomes.”

According to the National Institutes of Health (NIH), ADHD is treated with stimulants such as Methylphenidate (Ritalin, Metadate, Concerta, Daytrana), Amphetamine (Adderall), or Dextroamphetamine (Dexedrine, Dextrostat). These drugs have been approved by the Food and Drug Administration (FDA) for children as young as 6 years old.

The accepted treatment of ADHD has a list of dangerous side effects such as:

• Being anti-social or withdrawn
• Feeling hopeless, worthless
• Extreme suicidal thoughts
• Panic attacks
• Insomnia
• Aggressive and/or violent behavior
• Sudden changes in mood/behavior

Dr. Fred Baughman, child neurologist and ADHD researcher states that the advent of ADHD diagnoses is a scheme to sell more anti-psychotic drugs to young children by the pharmaceutical corporations in conjunction with the psychiatric community. Baughman insists that a normal development in children has now been socially accepted as a neurological disorder that requires psychiatric treatment.

Annually, Ritalin sales reach the billions and Adderall has unquestionably surpassed the once-leading drug treatment for ADHD to become the drug of choice for pediatricians. However, doctors admit that the children “grow out of the symptoms of ADHD” and that none of the accepted pharmaceuticals actually cure the alleged disease.

Researchers, in keeping with the necessity for drugs to treat ADHD, claim that video games, television, and genetics are the causes of the “disease” while completely ignoring the chemical additives in processed foods that would be heightening a normal function in the neurological development of children.

Maida Galvez, M.D., director of pediatric environmental health at Mount Sinai School of Medicine, explains that:

Scientific evidence is limited to support the association between food additives and ADHD symptoms. Although it is possible that a very small group of children who are allergic to artificial colorings or preservatives may show improvement in symptoms on restriction diets, evidence is insufficient to recommend routine, widespread use of restriction diets to treat a child’s ADHD symptoms.

Artificial food coloring in addition to the preservative sodium benzoate was shown in studies to incited hyperactivity in children that had not been previously diagnosed with ADHD.

Drug corporations that benefit from this scheme are:

1. Johnson & Johnson
2. Shire
3. Eli Lilly

In 2010, there was an explosion of sales for drugs treating ADHD to the extent that manufacturers could not keep the drugs on the shelf. Without having a clear science of diagnosis, any psychiatrist could (and did) label as many children as possible with ADHD for the sake of profits to the pharmaceutical industry, as well as lending credibility to the interpretive world of psychiatry because this specialty analyzes emotional responses and behaviors without using scientific measurements or knowledge of causational disturbances that are reflected in real, physical diseases.

ADHD is one of the most lucrative schemes concocted by the psychiatric community in order to justify the development of pharmaceutical drugs that were already in production.

Susanne Posel is the Chief Editor of Occupy Corporatism. Our alternative news site is dedicated to reporting the news as it actually happens; not as it is spun by the corporately funded mainstream media. You can find us on our Facebook page .